European Medical Journal

What European Medical Journal does

European Medical Journal (EMJ), operated by European Medical Group Ltd, is an independent open-access medical publishing platform founded in 2012 and headquartered in London. The company distributes peer-reviewed clinical content, congress coverage, podcasts, webinars, interactive educational content, and clinical calculation tools across 19 therapeutic areas to healthcare professionals across Europe and the United States, with an American Medical Journal LLC entity serving the US market. The technology stack is a digital publishing platform at emjreviews.com delivering content under CC BY-NC 4.0 licensing, supplemented by a Congress Hub, podcast series (Onc Now, Hema Now), webinars, Medical Calculators Toolkit, and a CME platform (EMJ Learning), all built on standard web publishing infrastructure without disclosed APIs, SDKs, or proprietary AI/ML systems.

EMJ's business model is a hybrid B2B/B2C structure. On the demand side, the company sells sponsored content, symposium coverage, poster reviews, KOL interviews, and display advertising to pharmaceutical companies including AstraZeneca, Takeda, Regeneron, LEO Pharma, and Sobi, using quote-based, multi-year project pricing. On the supply side, content is distributed free of charge to physicians and clinicians across Europe through controlled circulation, with no article processing charges for independently commissioned or unsolicited content. Revenue is therefore concentrated on pharma sponsorship and advertising rather than reader subscriptions or author fees, with ABPI Code of Practice compliance and ISO 9001 quality certification supporting editorial integrity claims that are central to the value proposition.

Strategic positioning rests on credibility signals (DOAJ, Royal Society of Medicine, and Google Scholar indexing; British Library digital archiving), breadth of therapeutic coverage, and a multi-format content ecosystem. The company has expanded organically across therapeutic areas, content formats, and geographies (UK, Europe, US), with no disclosed external funding rounds, M&A activity, or leadership changes beyond CEO Spencer Gore. Customers are concentrated among a small number of large pharmaceutical sponsors, and AI capability is limited to internal research-gathering assistance with no AI-generated content.

Name

European Medical Journal

Legal name

European Medical Group Ltd

Website

https://emjreviews.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

101–250 employees

Short description

European Medical Journal is a London-based independent open-access medical publisher operating across 19 therapeutic areas, distributing peer-reviewed journals, podcasts, webinars, and congress coverage to healthcare professionals in Europe and the US, funded primarily through pharmaceutical company sponsored content and advertising partnerships.

Ownership category

akta.pro rank

Product category

Medical Publishing

NAICS

Newspaper, Periodical, Book, and Directory Publishers (5131)

SIC

Periodicals: Publishing Or Publishing & Printing (2721)

akta.pro primary industry

Scholarly Societies & Conference Proceedings Publishing (MPAJABAK)

akta.pro secondary industries

Medicine & Allied Health (Clinical) (EDAGABAG), Medical & Clinical Reference (Physicians, Nursing, Allied Health) (EDAGAGAA)

Keywords

• Medical journal publishing
• Peer-reviewed journals
• Continuing medical education
• Pharmaceutical content partnerships
• Medical congress coverage

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Pharmaceutical Industry Partnerships: EMJ obtains funding for publishing by working with partners from the Pharmaceutical Industry. Content that has been sponsored by a Partner contains a support statement at the start. Revenue is generated through sponsored symposium coverage, poster reviews, KOL interview articles, and promotional content for pharma clients.
2. Journal Advertising: EMJ accepts display advertising within its journals in accordance with ABPI Code of Practice. Adverts are clearly labelled and the decision around publication is made by the EMJ Creative Director.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

European Medical Journal (EMJ) is an independent, open-access medical publishing platform that produces peer-reviewed journals, podcasts, webinars, interactive content, and clinical calculator tools across 19 therapeutic areas. Revenue is generated primarily through pharmaceutical industry partnerships (sponsored symposium coverage, KOL interviews, poster reviews) and journal advertising, while content is distributed free of charge to healthcare professionals in Europe.

Product overview

European Medical Journal operates as a multi-platform medical publishing organization offering a portfolio of peer-reviewed journals and educational content. The core offerings include the EMJ Flagship Journal, AMJ (American Medical Journal), and EMJ GOLD premium content, supplemented by 19 therapeutic area-specific journals. The portfolio also includes interactive tools (Medical Calculators including DVT Risk Calculator, BMI Calculator, and others), podcast series (Onc Now, Hema Now), Congress Hub for conference coverage, interactive content (infographics, case studies), and webinars. Content is distributed through controlled circulation to healthcare professionals across Europe, with open-access licensing under CC BY-NC 4.0.

Differentiator

Problem solved

Functional benefit

Brands

• EMJ GOLD: Premium content section featuring interviews with industry leaders and pharma executives covering major medical congresses and developments in healthcare.
• American Medical Journal

Products and services

• European Medical Journal (EMJ) Flagship Primary flagship journal covering multiple therapeutic areas with peer-reviewed articles, reviews, and expert perspectives on clinical discoveries and medical advancements, distributed free to healthcare professionals.
• American Medical Journal (AMJ) US-focused journal brand providing coverage of medical congresses and clinical developments for healthcare professionals in the Americas, operating as a separate legal entity under Delaware law.
• EMJ GOLD Premium content section featuring industry interviews, expert perspectives, and analysis of pharmaceutical developments and healthcare innovations, including the 'Gold with Gore' CEO podcast.
• Therapeutic Area Journals Portfolio of 19 specialty-specific journals covering Allergy & Immunology, Cardiology, Dermatology, Diabetes, Gastroenterology, Hematology, Hepatology, Neurology, Oncology, Respiratory, Rheumatology, Urology, and other therapeutic areas.
• Medical Calculators (Toolkit) Suite of clinical calculator tools including Paediatric Growth Calculator, DVT Risk Calculator, Due Date Calculator, Mean Arterial Pressure (MAP) Calculator, and BMI Calculator, available free to healthcare professionals.
• Podcast Series Therapeutic area-specific podcasts including Onc Now (oncology), Hema Now (hematology), nephrology conversations, cardiology series, Bias Equity and the Future of Women's Heart Care, Kidney Stone Disease, and the 'Gold with Gore' CEO podcast.
• Congress Hub Coverage platform for leading medical congresses providing expert insights, key developments, and live on-site reporting from major clinical medicine conferences.
• Webinars Live and recorded educational webinars featuring expert speakers discussing latest clinical strategies and treatment approaches, including the EMJ Allergy and Immunology webinar series and sponsored symposium coverage from congresses.
• EMJ Interactive Content Interactive educational materials including infographics, interactive articles, case studies, and video content across multiple therapeutic areas.

Quantifiable outcome

• Indexed on major academic databases including DOAJ, Royal Society of Medicine, and Google Scholar
• +1 more outcomes

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Pharmaceutical Industry PartnerscoreStrategic or Co-development PartnerEMJ works with pharmaceutical industry partners for funding and sponsored content. Partners include companies such as AstraZeneca, Takeda, Regeneron, LEO Pharma, and others. Sponsorship includes symposium coverage, poster reviews, KOL interviews, and promotional educational content. All sponsored content contains support statements and undergoes quality control checks by independent medical writers.
• Medical/Scientific SocietiescoreStrategic or Co-development PartnerEMJ maintains unrivalled collaborations with eminent independent industry bodies and collaborating societies. Coverage includes EHA (European Hematology Association), EORTC, ISGE (International Society of Gynaecological Endocrinology), RCOG (Royal College of Obstetricians and Gynaecologists), and others. Societies provide congress access and scientific legitimacy for content coverage.
• LEO PharmaminorGTM or Marketing PartnerLEO Pharma A/S fully funded the development and publication of promotional content on topical pan-JAK inhibitor treatment for chronic hand eczema, intended for healthcare professionals.
• Sobi (Swedish Orphan Biovitrum)minorGTM or Marketing PartnerSobi sponsored symposium at EHA 2026 Congress covered R/R DLBCL treatment gaps and next moves, recorded and published through EMJ platform.
• British LibraryminorOthersEMJ journals are digitally archived by the British Library, providing long-term preservation and access services.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• The Lancet: The Lancet is a flagship peer-reviewed medical journal brand with sister specialty titles — directly comparable to EMJ's flagship journal + 19 specialty journals architecture serving clinicians globally.
• Dove Medical Press: Dove Medical Press is an open-access medical publisher specializing in peer-reviewed journals across therapeutic areas — closely comparable to EMJ's open-access, no-APC model and specialty journal breadth.
• Karger Publishers: Karger is a medical and scientific publishing house with a portfolio of peer-reviewed specialty journals — directly comparable in therapeutic-area specialization and clinician-targeted content delivery.
• BMJ: British Medical Journal is a peer-reviewed medical publisher with a flagship journal, specialty titles across therapeutic areas, and CME offerings — directly comparable to EMJ's flagship + specialty journal portfolio and peer-reviewed B2B/HCP model.
• MDPI: MDPI is a large open-access publisher with broad medical/scientific journal coverage — directly comparable to EMJ's open-access, multi-journal, therapeutic-area publishing model.
• Frontiers: Frontiers is an open-access scientific publisher with a portfolio of peer-reviewed medical journals — directly comparable to EMJ's open-access peer-reviewed journal model serving clinician/researcher audiences.

Broad incumbents

• Wiley (Open Access / Medical journals): Wiley publishes a large portfolio of peer-reviewed medical journals including open-access titles — overlapping with EMJ's specialty journal and OA model, but operating at much greater scale across many non-medical disciplines.
• Elsevier (ClinicalKey / The Lancet family): Elsevier's ClinicalKey and journal division hosts major peer-reviewed medical journals and clinical-decision content — overlapping with EMJ's peer-reviewed journal + clinical-calculator-style clinician tools, but as part of a global incumbent STM stack.
• Springer Nature (Springer Healthcare): Springer Nature operates one of the largest medical journal portfolios plus Springer Healthcare communications — overlapping with EMJ's specialty journal coverage and pharma-sponsored content, but as part of a much broader STM and books portfolio.
• Wolters Kluwer Health: Wolters Kluwer Health publishes Lippincott medical journals and clinical decision tools (UpToDate) — comparable to EMJ's journal + clinical calculator suite, at much larger incumbent scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/EMJReviews
• Facebookfacebook.com/emjreviews

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Medical Journal